BHCM
ASTH icon

Brevan Howard Capital Management’s Astrana Health ASTH Stock Holding History

Brevan Howard Capital Management’s Portfolio ASTH Stock Details ASTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-9,290
Closed -$228K – 2652
2026
Q1 		$228K Buy
+9,290
New +$220K ﹤0.01% 1812
2025
Q3 		– Sell
-11,140
Closed -$277K – 2345
2025
Q2 		$277K Buy
+11,140
New +$314K ﹤0.01% 1584
2025
Q1 		– Sell
-15,706
Closed -$495K – 1529
2024
Q4 		$495K Buy
+15,706
New +$746K ﹤0.01% 625

Other funds holding ASTH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
3C
325 Capital New York $419M AUM 75.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Brevan Howard Capital Management's ASTH Position: Q2 2026 in Review

Brevan Howard Capital Management sold out of Astrana Health (ASTH) in Q2 2026, closing a stake of 9,290 shares — an estimated $228K sold.

Brevan Howard Capital Management first reported a position in ASTH in Q4 2024 and held it in 3 quarters. The position peaked at $495K in Q4 2024. 209 funds tracked by Wall St. Rank hold ASTH as of Q2 2026.

  • Brevan Howard Capital Management reported no remaining Astrana Health position as of Q2 2026 after selling out during the quarter.
  • Brevan Howard Capital Management sold 9,290 Astrana Health shares in Q2 2026, an estimated $228K.
  • Brevan Howard Capital Management first reported a position in Astrana Health in Q4 2024 and held it in 3 quarters.
  • Brevan Howard Capital Management's Astrana Health position peaked at $495K in Q4 2024.
  • 209 funds tracked by Wall St. Rank held Astrana Health as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.